We are analyzing https://link.springer.com/article/10.1007/s10456-009-9134-8.

Title:
A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents | Angiogenesis
Description:
The discovery of molecules with anti-angiogenic properties has led to promising new strategies for the treatment of diseases characterized by excessive new vessel growth, such as cancer and haemangioma. We have assessed the effects of DNA-damaging and cytoskeletal-disrupting agents in vitro on several endothelial cell functions. We report that bleomycin, mitomycin C and cytoskeletal-disrupting drugs (2-methoxyestradiol, taxol, vincristine, vinblastine, colchicine, nocodazole, and cytochalasin D) exhibit anti-angiogenic activities of varying potency. Bleomycin and the various cytoskeletal-disrupting drugs inhibited endothelial cell migration, while mitomycin C had a marginal effect. Both DNA-damaging and cytoskeletal-disrupting drugs decreased endothelial cell growth in a dose-dependent manner, and this was accompanied by the induction of apoptosis. The growth inhibitory and apoptotic effects of cytoskeletal-disrupting drugs were the most pronounced. We also show that both classes of drugs inhibited capillary-like tube formation in an assay of in vitro angiogenesis, with cytoskeletal-disrupting agents inhibiting in vitro angiogenesis with greater potency. A targeted approach incorporating several compounds with different mechanisms of action may be useful for the treatment of angiogenesis-dependent diseases such as hemangiomas of infancy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Social Networks

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

article, google, scholar, pubmed, cas, angiogenesis, cell, pepper, endothelial, cytoskeletaldisrupting, growth, bleomycin, vitro, treatment, drugs, antiangiogenic, agents, apoptosis, hemangiomas, access, surg, privacy, cookies, content, research, michael, cancer, res, publish, search, effects, dnadamaging, mabeta, vascular, basic, author, pretoria, data, information, log, journal, mitomycin, methoxyestradiol, induction, formation, therapy, open, discover, pediatr, hemangioma,

Topics {✒️}

cytoskeletal-disrupting agents inhibiting month download article/chapter potential anti-angiogenic agents cytoskeletal-disrupting agents exhibit anti-angiogenic activities multi-scale mathematical modelling cytoskeletal-disrupting drugs plasminogen activator-plasmin system tube formation endothelial cell functions drugs inhibited capillary full article pdf endothelial cell apoptosis article angiogenesis aims national research foundation cell cycle control programmed cell death privacy choices/manage cookies anti-angiogenic properties related subjects article mabeta medical research council anti-angiogenic effects drug-induced apoptosis plasminogen activator expression pepper ms targeted approach incorporating angiostatin induce apoptosis european economic area congenital vascular malformations corinne di sanza prof piet becker mandriota sj conditions privacy policy tumour growth dose-dependent manner internucleosomal dna fragmentation angiogenesis-dependent diseases author information authors article log accepting optional cookies mulliken jb inducing haemangioma regression excellent technical assistance university medical centre microtubule inhibitors 2-methoxyestradiol vitro toxicity studies intralesional bleomycin injection complicated cutaneous hemangiomas cell shape

Schema {🗺️}

WebPage:
      mainEntity:
         headline:A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents
         description:The discovery of molecules with anti-angiogenic properties has led to promising new strategies for the treatment of diseases characterized by excessive new vessel growth, such as cancer and haemangioma. We have assessed the effects of DNA-damaging and cytoskeletal-disrupting agents in vitro on several endothelial cell functions. We report that bleomycin, mitomycin C and cytoskeletal-disrupting drugs (2-methoxyestradiol, taxol, vincristine, vinblastine, colchicine, nocodazole, and cytochalasin D) exhibit anti-angiogenic activities of varying potency. Bleomycin and the various cytoskeletal-disrupting drugs inhibited endothelial cell migration, while mitomycin C had a marginal effect. Both DNA-damaging and cytoskeletal-disrupting drugs decreased endothelial cell growth in a dose-dependent manner, and this was accompanied by the induction of apoptosis. The growth inhibitory and apoptotic effects of cytoskeletal-disrupting drugs were the most pronounced. We also show that both classes of drugs inhibited capillary-like tube formation in an assay of in vitro angiogenesis, with cytoskeletal-disrupting agents inhibiting in vitro angiogenesis with greater potency. A targeted approach incorporating several compounds with different mechanisms of action may be useful for the treatment of angiogenesis-dependent diseases such as hemangiomas of infancy.
         datePublished:2009-02-12T00:00:00Z
         dateModified:2009-02-12T00:00:00Z
         pageStart:81
         pageEnd:90
         sameAs:https://doi.org/10.1007/s10456-009-9134-8
         keywords:
            Angiogenesis
            Hemangioma
            Bleomycin
            Mitomycin C
            Cytoskeletal-disrupting agents
            Endothelial cell
            Cell growth
            Cell migration
            Tube formation
            Cancer Research
            Biomedicine
            general
            Cell Biology
            Cardiology
            Ophthalmology
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-009-9134-8/MediaObjects/10456_2009_9134_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-009-9134-8/MediaObjects/10456_2009_9134_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-009-9134-8/MediaObjects/10456_2009_9134_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-009-9134-8/MediaObjects/10456_2009_9134_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-009-9134-8/MediaObjects/10456_2009_9134_Fig5_HTML.gif
         isPartOf:
            name:Angiogenesis
            issn:
               1573-7209
               0969-6970
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Peace Mabeta
               affiliation:
                     name:University of Pretoria
                     address:
                        name:Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael S. Pepper
               affiliation:
                     name:University of Pretoria
                     address:
                        name:Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
                        type:PostalAddress
                     type:Organization
                     name:University Medical Centre
                     address:
                        name:Département de Médecine Génétique et Développement, University Medical Centre, Geneva, Switzerland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents
      description:The discovery of molecules with anti-angiogenic properties has led to promising new strategies for the treatment of diseases characterized by excessive new vessel growth, such as cancer and haemangioma. We have assessed the effects of DNA-damaging and cytoskeletal-disrupting agents in vitro on several endothelial cell functions. We report that bleomycin, mitomycin C and cytoskeletal-disrupting drugs (2-methoxyestradiol, taxol, vincristine, vinblastine, colchicine, nocodazole, and cytochalasin D) exhibit anti-angiogenic activities of varying potency. Bleomycin and the various cytoskeletal-disrupting drugs inhibited endothelial cell migration, while mitomycin C had a marginal effect. Both DNA-damaging and cytoskeletal-disrupting drugs decreased endothelial cell growth in a dose-dependent manner, and this was accompanied by the induction of apoptosis. The growth inhibitory and apoptotic effects of cytoskeletal-disrupting drugs were the most pronounced. We also show that both classes of drugs inhibited capillary-like tube formation in an assay of in vitro angiogenesis, with cytoskeletal-disrupting agents inhibiting in vitro angiogenesis with greater potency. A targeted approach incorporating several compounds with different mechanisms of action may be useful for the treatment of angiogenesis-dependent diseases such as hemangiomas of infancy.
      datePublished:2009-02-12T00:00:00Z
      dateModified:2009-02-12T00:00:00Z
      pageStart:81
      pageEnd:90
      sameAs:https://doi.org/10.1007/s10456-009-9134-8
      keywords:
         Angiogenesis
         Hemangioma
         Bleomycin
         Mitomycin C
         Cytoskeletal-disrupting agents
         Endothelial cell
         Cell growth
         Cell migration
         Tube formation
         Cancer Research
         Biomedicine
         general
         Cell Biology
         Cardiology
         Ophthalmology
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-009-9134-8/MediaObjects/10456_2009_9134_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-009-9134-8/MediaObjects/10456_2009_9134_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-009-9134-8/MediaObjects/10456_2009_9134_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-009-9134-8/MediaObjects/10456_2009_9134_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-009-9134-8/MediaObjects/10456_2009_9134_Fig5_HTML.gif
      isPartOf:
         name:Angiogenesis
         issn:
            1573-7209
            0969-6970
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Peace Mabeta
            affiliation:
                  name:University of Pretoria
                  address:
                     name:Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael S. Pepper
            affiliation:
                  name:University of Pretoria
                  address:
                     name:Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
                     type:PostalAddress
                  type:Organization
                  name:University Medical Centre
                  address:
                     name:Département de Médecine Génétique et Développement, University Medical Centre, Geneva, Switzerland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Angiogenesis
      issn:
         1573-7209
         0969-6970
      volumeNumber:12
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Pretoria
      address:
         name:Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
         type:PostalAddress
      name:University of Pretoria
      address:
         name:Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
         type:PostalAddress
      name:University Medical Centre
      address:
         name:Département de Médecine Génétique et Développement, University Medical Centre, Geneva, Switzerland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Peace Mabeta
      affiliation:
            name:University of Pretoria
            address:
               name:Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
               type:PostalAddress
            type:Organization
      name:Michael S. Pepper
      affiliation:
            name:University of Pretoria
            address:
               name:Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
               type:PostalAddress
            type:Organization
            name:University Medical Centre
            address:
               name:Département de Médecine Génétique et Développement, University Medical Centre, Geneva, Switzerland
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
      name:Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
      name:Département de Médecine Génétique et Développement, University Medical Centre, Geneva, Switzerland
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(112)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Foundation
Prism.js

CDN Services {📦}

Crossref

6.04s.

LINK . SPRINGER . COM {}